Judith Balmañà
Hebron University(PS)Universitat Autònoma de Barcelona(ES)Weatherford College(US)Vall d'Hebron Institut de Recerca(ES)Institut Català d'Oncologia(ES)Tumour Institute of Tuscany(IT)Vall d'Hebron Hospital Universitari(ES)Pacific Biomarkers (United States)(US)Cancer Genetics (United States)(US)Vall d'Hebron Institute of Oncology(ES)Vall d'Hebron Institute of Oncology
Publications by Year
Research Areas
BRCA gene mutations in cancer, PARP inhibition in cancer therapy, Genetic factors in colorectal cancer, DNA Repair Mechanisms, Cancer Genomics and Diagnostics
Most-Cited Works
- → Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation(2014)1,667 cited
- → ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making(2012)1,518 cited
- → A decade of clinical development of PARP inhibitors in perspective(2019)703 cited
- → Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer(2017)542 cited
- → Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer(2012)475 cited
- → Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer(2017)464 cited